Valion Bio, Inc.
VBIO
$1.10
-$0.01-0.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.89% | -81.41% | -52.53% | -1.42% | 34.15% |
| Total Depreciation and Amortization | -98.90% | -100.00% | -96.88% | -97.83% | 480.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.52% | 672.00% | 183.87% | 100.00% | 548.89% |
| Change in Net Operating Assets | 98.93% | 140.38% | 36.52% | 282.21% | -324.40% |
| Cash from Operations | -67.55% | -41.86% | -41.96% | 46.64% | 23.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 2,760.00% | -41.31% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -480.95% | 180.36% | -314.75% | 55.74% | -- |
| Cash from Financing | 887.35% | 4,504.12% | -28.68% | 234.43% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,017.11% | 250.66% | -74.57% | 22.81% | 89.46% |